Carr Douglas (CIK 1867173) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-05). Recent activity: Sell IPSC (275 shares), Sell IPSC (1,654 shares), Sell IPSC (249 shares), Sell IPSC (264 shares), Sell IPSC (7,043 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 275 | $544 |
| 2026-06-15 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 1,654 | $3,692 |
| 2026-06-09 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 249 | $526 |
| 2026-05-06 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 264 | $618 |
| 2026-03-16 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 7,043 | $17,960 |
| 2026-03-11 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 247 | $627 |
| 2026-02-05 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 323 | $588 |
| 2026-02-04 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Buy | 110,000 | $0 |
| 2025-12-10 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 257 | $136 |
| 2025-11-05 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 292 | $172 |
| 2025-09-10 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 263 | $132 |
| 2025-08-06 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 296 | $157 |
| 2025-06-11 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 4,904 | $3,040 |
| 2025-05-07 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 295 | $162 |
| 2025-03-12 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Sell | 1,240 | $769 |
| 2025-03-12 | Century Therapeutics, Inc. (IPSC) | SVP Finance & Operations | Buy | 95,625 | $0 |
Source: SEC Form 4 filings · as of 2026-08-05